Skip to main content
. 2022 Nov 21;10:1060850. doi: 10.3389/fcell.2022.1060850

TABLE 1.

A summary of the main molecular findings and their potential implications in PEVs.

Molecular cargo Type of PEV Physiological functions/Pathological role References
(HLA)-G5, B7-H1 and B7-H3 Placental exosomes Immune tolerance. Dysregulation of HLA components are related to different obstetric complications Kshirsagar et al. (2012)
miR-29a-3p Placental exosomes Enhanced expression of PDL-1 and M2 polarization in normal pregnancies Bai et al. (2022)
NKGD2 ligands (i.e. ULBP and MIC-A and B Placental exosomes Immunosupressive role on NK cells Hedlund et al. (2009)
miR-517a-3p Placental exosomes Targeting of PRKG1 in NK cells Kambe et al. (2014)
PDL-1, PDL-2, TRAIL and FasL Placental exosomes Immunomodulatory effects in different populations Mincheva-Nilsson, (2021)
TGF-β1 and IL-10 Placental microvesicles Modulation of caspase 3 activity in CD56dim NK cells Nardi et al. (2016)
IL-1β Placental microvesicles More abundant in placental microvesicles during the first trimester or under pathological conditions Holder et al. (2012)
miRNA members of the chromosome 19 miRNA cluster Placental exosomes Attenuate viral replication in recipient cells by the induction of autophagy Delorme-Axford et al. (2013); Bayer et al. (2015))
PLAP Placental exosomes and MVs Marker of PEVs; Transfer of maternal IgG to the fetus at the placenta surface and stimulate DNA synthesis and cell proliferation in fetal fibroblasts. There is a direct correlation between (PLAP + ve ratio) and birth weight percentile. Reduced PLAP + ve ratio is associated with different obstetric complications. A single case report found a dramatic increase of PLAP associated with preterm birth Dragovic et al. (2015); Jin and Menon, (2018); Miranda et al. (2018)
Goswamia et al. (2006); Orozco et al. (2009); Chen et al. (2012); Pillay et al. (2016)
Gilbert et al. (2008)
Miranda et al. (2018)
Ferianec and Linhartova, (2011)
Eng and Flt-1 Placental exosomes and MVs Reduced bioavailability of VEGF abnd PlGF in preeclampsia Tannetta et al. (2013)
sFlt-1 Syncytial nuclear aggregates increased syncytial knots and systemic vascular injury in preeclampsia Rajakumar et al. (2012); Buurma et al. (2013)
TFPI Microvesicles Enhanced bioavailability of TF and procoagulant activity in women with preeclampsia Aharon et al. (2009)
TF Syncytiotrophoblast microvesicles Altered hemostasis in preeclamptic women Gardiner et al. (2011)
mucin-1 Not specified Impairs EVT invasion and integrin signaling in preeclampsia Shyu et al. (2011); Tannetta et al. (2017)
Integrins Syncytiotrophoblast microvesicles Decreased in preeclampsia Baig et al. (2014)
syncytin- 1 and -2 Placental exosomes Syncytin 2 is decreased in placental exosomes of women with preeclampsia, affecting to their internalization Vargas et al. (2011); Vargas et al. (2014)
miR-155 Placental exosomes Decrease NO production and eNOS in primary HUVECs Shen et al. (2018)
miR-141 Placental exosomes Augmented in preeclampsia; Induction of T cell proliferation Ospina-Prieto et al. (2016)
miR‐548c‐5p Placental exosomes Downregulation of expression of this miRNA alters macrophage behavior and promote the expression of the proinflammatory cytokines IL-12, TNF‐α and nuclear translocation of NF‐κB Wang et al. (2019)
HMGB1 Syncytial nuclear aggregates Increased in preeclampsia Proinflammatory actions in preeclamptic women Zhang et al. (2020)
PP13 Not specified Reductions of this protein is associated with aberrant immunopathological mechanisms Sammar et al. (2018)
hsa-miR-210, hsa-miR-486-1-5p and hsa-miR-486-2-5p, circular DNA Placental exosomes Elevated in preeclampsia, being evaluated as potential diagnostic markers Gillet et al. (2019)
CAMK2β, PAPP-A Not specified Insulin signaling and glucose metabolic routes Jayabalan et al. (2019a)
DDPIV Greater levels and activity in placental extracellular vesicles in women with gestational diabetes, modulating glucose-dependent insulin secretion Kandzija et al. (2019)
miR-520a-5p Not specified Downregulated in women suffering preeclampsia and gestational hypertension and who later developed FGR Hromadnikova et al. (2019)